Orally active indole N-oxide PDE4 inhibitors-Reference-Cited by-同舟云学术

Orally active indole N-oxide PDE4 inhibitors

Published:1998-11 Issue:21 Volume:8 Page:3053-3058
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Hulme Christopher,Mathew Rose,Moriarty Kevin,Miller Bruce,Ramanjulu Mercy,Cox Paul,Souness John,Page Ken M.,Uhl Joanne,Travis Jeffrey,Labaudiniere Richard,Huang Fu-chih,Djuric Stevan W.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference17 articles.

1. Beneficial effects of tumour necrosis factor-alpha (TNF-α) blockade in rheumatoid arthritis (RA)

2. Phosphodiesterase type IV inhibitors as antiinflammatory agents

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of Water Molecules in the Ligand Binding Domain of PDE4B and PDE4D: Virtual Screening Based Molecular Docking of Some Active Scaffolds;Current Computer-Aided Drug Design;2019-07-01

2. The Diversity of Heterocyclic N-oxide Molecules: Highlights on their Potential in Organic Synthesis, Catalysis and Drug Applications;Current Organic Chemistry;2019-07-01

3. ChemInform Abstract: Orally Active Indole N-Oxide PDE4 Inhibitors.;ChemInform;2010-06-17

4. Comparative molecular field analysis (CoMFA) for phosphodiesterase (PDE) IV inhibitors;Journal of Molecular Structure: THEOCHEM;2007-10

5. Asthma and Chronic Obstructive Pulmonary Disease;Comprehensive Medicinal Chemistry II;2007